Literature DB >> 2898487

Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder.

A G Turhan1, R K Humphries, J D Cashman, D A Cuthbert, C J Eaves, A C Eaves.   

Abstract

We have used restriction fragment length polymorphism analysis to study the clonal involvement of the blood cells in a woman with myeloproliferative disease, whose initially high platelet count (940,000/microliter) spontaneously decreased during a normal pregnancy but then returned rapidly to the same high level after delivery of her child. Analysis of her erythroid progenitors showed the presence of erythropoietin-independent progenitors before, during, and after her pregnancy, consistent with a diagnosis of myeloproliferative disease, and persistence of the abnormal clone throughout the period of study. Analysis of DNA from her blood granulocytes showed these to be polyclonal at mid-pregnancy, when her platelet count had decreased to normal values, in comparison to the monoclonal pattern exhibited by her blood granulocytes 3 mo postpartum, when her platelet count was again elevated. These results demonstrate a partial conversion to normal, polyclonal hemopoiesis during her pregnancy and suggest a previously unanticipated differential sensitivity of normal and neoplastic hemopoietic cells to physiological changes associated with this state.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898487      PMCID: PMC442654          DOI: 10.1172/JCI113549

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm.

Authors:  K Imakawa; R V Anthony; M Kazemi; K R Marotti; H G Polites; R M Roberts
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

Review 2.  Erythropoiesis in culture.

Authors:  A C Eaves; C J Eaves
Journal:  Clin Haematol       Date:  1984-06

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.

Authors:  T Goto; M Nishikori; Z Arlin; T Gee; S Kempin; J Burchenal; A Strife; D Wisniewski; C Lambek; C Little; S Jhanwar; R Chaganti; B Clarkson
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

5.  Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

Authors:  J W Singer; P J Fialkow; L Steinmann; V Najfeld; S J Stein; W A Robinson
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

6.  Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses.

Authors:  C J Gregory; A C Eaves
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

7.  Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Authors:  L Coulombel; D K Kalousek; C J Eaves; C M Gupta; A C Eaves
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245

8.  Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukaemia (CML). I. Persistence of Ph1-negative committed progenitors that are suppressed from differentiating in vivo.

Authors:  I D Dubé; C M Gupta; D K Kalousek; C J Eaves; A C Eaves
Journal:  Br J Haematol       Date:  1984-04       Impact factor: 6.998

9.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera.

Authors:  C J Eaves; A C Eaves
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

10.  CM Affi-Gel Blue chromatography of human urine: a simple one-step procedure for obtaining erythropoietin suitable for in vitro erythropoietic progenitor assays.

Authors:  G Krystal; C J Eaves; A C Eaves
Journal:  Br J Haematol       Date:  1984-11       Impact factor: 6.998

View more
  2 in total

1.  Splenic thrombosis complicating pregnancy in patients with poor obstetrical outcome. A report of four cases.

Authors:  A Pajor; D Lehoczky
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

2.  Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.

Authors:  Alison R Moliterno; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak
Journal:  Exp Hematol       Date:  2008-08-23       Impact factor: 3.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.